Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial
- Author
- COLOMBEL, Jean-Frédéric1 ; SANDBORN, William J2 ; RUTGEERTS, Paul3 ; KAMM, Michael A4 ; YU, Andrew P5 ; WU, Eric Q5 ; POLLACK, Paul F6 ; LOMAX, Kathleen G6 ; JINGDONG CHAO7 ; MULANI, Parvez M7
[1] Department of Hepatogastroenterology, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France
[2] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States
[3] Department of Gastro-Enterologie, University Hospital of Gasthuisberg, Leuven, Belgium
[4] Department of Medicine, St Vincent's Hospital & Melbourne University, Melbourne, Victoria, Australia
[5] Analysis Group Inc, Boston, Massachusetts, United States
[6] Medical Affairs-Immunology, Abbott Laboratories, Parsippany, New Jersey, United States
[7] Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, Illinois, United States - Source
The American journal of gastroenterology. 2009, Vol 104, Num 5, pp 1170-1179, 10 p ; ref : 8 ref
- ISSN
- 0002-9270
- Scientific domain
- Gastroenterology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adalimumab Antipsoriasique Antirhumatismal Entérite de Crohn Etude comparative Gastroentérologie Immunomodulateur Traitement Anti-TNF-alpha Anticorps monoclonal Anticytokine Cytokine Facteur nécrose tumorale α Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
- Keyword (en)
- Adalimumab Antipsoriatic agent Antirheumatic agent Crohn disease Comparative study Gastroenterology Immunomodulator Treatment Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Cytokine Tumor necrosis factor α Inflammatory disease Digestive diseases Intestinal disease
- Keyword (es)
- Adalimumab Antipsoriásico Antireumático Enteritis Crohn Estudio comparativo Gastroenterología Inmunomodulador Tratamiento Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Citoquina Factor necrosis tumoral α Enfermedad inflamatoria Aparato digestivo patología Intestino patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21433059
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/ajg.2009.59 
https://dx.doi.org/10.1038/ajg.2009.59
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The American journal of gastroenterology\";s:9:\"\u0000*\u0000stitle\";s:20:\"Am. j. gastroenterol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1170\";s:8:\"\u0000*\u0000epage\";s:4:\"1179\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9270\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"COLOMBEL\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Jean-Fr\u00e9d\u00e9ric\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"SANDBORN, William J\";i:1;s:15:\"RUTGEERTS, Paul\";i:2;s:15:\"KAMM, Michael A\";i:3;s:12:\"YU, Andrew P\";i:4;s:10:\"WU, Eric Q\";i:5;s:15:\"POLLACK, Paul F\";i:6;s:17:\"LOMAX, Kathleen G\";i:7;s:13:\"JINGDONG CHAO\";i:8;s:16:\"MULANI, Parvez M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The American journal of gastroenterology\";s:9:\"\u0000*\u0000stitle\";s:20:\"Am. j. gastroenterol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1170\";s:8:\"\u0000*\u0000epage\";s:4:\"1179\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9270\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"COLOMBEL\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Jean-Fr\u00e9d\u00e9ric\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"SANDBORN, William J\";i:1;s:15:\"RUTGEERTS, Paul\";i:2;s:15:\"KAMM, Michael A\";i:3;s:12:\"YU, Andrew P\";i:4;s:10:\"WU, Eric Q\";i:5;s:15:\"POLLACK, Paul F\";i:6;s:17:\"LOMAX, Kathleen G\";i:7;s:13:\"JINGDONG CHAO\";i:8;s:16:\"MULANI, Parvez M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The American journal of gastroenterology\";s:9:\"\u0000*\u0000stitle\";s:20:\"Am. j. gastroenterol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1170\";s:8:\"\u0000*\u0000epage\";s:4:\"1179\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9270\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"COLOMBEL\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Jean-Fr\u00e9d\u00e9ric\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"SANDBORN, William J\";i:1;s:15:\"RUTGEERTS, Paul\";i:2;s:15:\"KAMM, Michael A\";i:3;s:12:\"YU, Andrew P\";i:4;s:10:\"WU, Eric Q\";i:5;s:15:\"POLLACK, Paul F\";i:6;s:17:\"LOMAX, Kathleen G\";i:7;s:13:\"JINGDONG CHAO\";i:8;s:16:\"MULANI, Parvez M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The American journal of gastroenterology\";s:9:\"\u0000*\u0000stitle\";s:20:\"Am. j. gastroenterol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1170\";s:8:\"\u0000*\u0000epage\";s:4:\"1179\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9270\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"COLOMBEL\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Jean-Fr\u00e9d\u00e9ric\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"SANDBORN, William J\";i:1;s:15:\"RUTGEERTS, Paul\";i:2;s:15:\"KAMM, Michael A\";i:3;s:12:\"YU, Andrew P\";i:4;s:10:\"WU, Eric Q\";i:5;s:15:\"POLLACK, Paul F\";i:6;s:17:\"LOMAX, Kathleen G\";i:7;s:13:\"JINGDONG CHAO\";i:8;s:16:\"MULANI, Parvez M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/ajg.2009.59\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:9:\"\u0000*\u0000jtitle\";s:40:\"The American journal of gastroenterology\";s:9:\"\u0000*\u0000stitle\";s:20:\"Am. j. gastroenterol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"104\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1170\";s:8:\"\u0000*\u0000epage\";s:4:\"1179\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9270\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"COLOMBEL\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Jean-Fr\u00e9d\u00e9ric\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:19:\"SANDBORN, William J\";i:1;s:15:\"RUTGEERTS, Paul\";i:2;s:15:\"KAMM, Michael A\";i:3;s:12:\"YU, Andrew P\";i:4;s:10:\"WU, Eric Q\";i:5;s:15:\"POLLACK, Paul F\";i:6;s:17:\"LOMAX, Kathleen G\";i:7;s:13:\"JINGDONG CHAO\";i:8;s:16:\"MULANI, Parvez M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
